Koyfin Home > Directory > Health Care > Aimmune Therap > Net Debt / (EBITDA-CAPEX)

Aimmune Therap Net Debt / (EBITDA-CAPEX) Chart (AIMT)

Aimmune Therap annual/quarterly Net Debt / (EBITDA-CAPEX) from 2014 to 2020.
  • Aimmune Therap Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $1m a 17.53% increase of 0m year over year
  • Aimmune Therap Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $1m a 4.37% increase of 0m year over year
  • Aimmune Therap Annual Net Debt / (EBITDA-CAPEX) for 2019 was $0m a -279.74% decrease of -1m from 2018
  • Aimmune Therap Annual Net Debt / (EBITDA-CAPEX) for 2018 was $1m a 3.42% increase of 0m from 2017
  • Aimmune Therap Annual Net Debt / (EBITDA-CAPEX) for 2017 was $1m a -113.52% decrease of -1m from 2016
Other Ratios Metrics:
  • Aimmune Therap Total Debt / Capital for the quarter ending December 12, 2017 was $0m
  • Aimmune Therap Other Liabilities for the quarter ending December 12, 2018 was $3m a 9.82% increase of 0m year over year
  • Aimmune Therap Total Debt / Equity for the quarter ending December 12, 2017 was $0m
View Chart On Koyfin

Quarterly AIMT Net Debt / (EBITDA-CAPEX) Data

06/2020$1m
03/2020$1m
12/2019$0m
09/2019$1m
06/2019$1m
03/2019$1m
12/2018$1m
09/2018$1m
06/2018$1m
03/2018$2m

Annual AIMT Net Debt / (EBITDA-CAPEX) Data

2019$0m
2018$1m
2017$1m
2016$3m
2015$5m
2014$0m
2013$2m